Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS

University of Alberta

$4,950.00

Urine-Based Biomarkers of Bone Metabolism as Measures of Osteoporosis Drug Regimen Adherence

FY 2009-10

Summary
This research project will examine the effects of several well characterized bone drug classes when they used to treat Osteoporosis (OP), namely the bisphosphonates (BPs), the selective estrogen receptor modulators (SERMs) and Calcitonin (CT). A comparative nalysis of those bone drugs will be conducted in order to identify urine-based biomarker molecules of bone metabolism in order to gauge the effectiveness (and/or partient compliance) to the prescribed osteoporosis medication. The pharmacy student will initially examine the literature from clinical trials and current pharmaceutical research to identify and table established and emerging bone biomarker candidates. The most useful bone biomarkers will then be assayed from patient urine samples as a proof-of-principle for monitoring patient adherence to therapy, using lab-based enzyme-linked immunosorbent assay (ELISA) techniques, in order to ascertain the ability to discern fluctuations in patient adherence to the given osteoporosis therapeutic regimen.
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
205421
Name
Kwon SoHyea
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Urine-Based Biomarkers of Bone Metabolism as Measures of Osteoporosis Drug Regimen Adherence
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Antiresorptive Drugs; Bisphosphonates; Bone; Calcitonin; Cartilage; Elisa; Osteoarthritis; Urine Biomarkers
Abstract
This research project will examine the effects of several well characterized bone drug classes when they used to treat Osteoporosis (OP), namely the bisphosphonates (BPs), the selective estrogen receptor modulators (SERMs) and Calcitonin (CT). A comparative nalysis of those bone drugs will be conducted in order to identify urine-based biomarker molecules of bone metabolism in order to gauge the effectiveness (and/or partient compliance) to the prescribed osteoporosis medication. The pharmacy student will initially examine the literature from clinical trials and current pharmaceutical research to identify and table established and emerging bone biomarker candidates. The most useful bone biomarkers will then be assayed from patient urine samples as a proof-of-principle for monitoring patient adherence to therapy, using lab-based enzyme-linked immunosorbent assay (ELISA) techniques, in order to ascertain the ability to discern fluctuations in patient adherence to the given osteoporosis therapeutic regimen.
Competitiondate
201003
Approvedterm2
0 yr 3 mths
Pinamesdelim
Kwon, SoHyea
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~
University of Alberta - $4,950 Grant (2009-10) | Canada Spends